Zentalis Pharmaceuticals, INC. (ZNTL) — 10-K Filings
All 10-K filings from Zentalis Pharmaceuticals, INC.. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (2)
-
Zentalis Bets Big on Azenosertib Amidst Mounting Losses
— Mar 26, 2026 Risk: high
Zentalis Pharmaceuticals, Inc. (ZNTL) reported significant net losses for the fiscal year ended December 31, 2025, and expects these losses to continue as it ha -
Zentalis Pharmaceuticals Files 2024 10-K
— Mar 26, 2025 Risk: medium
Zentalis Pharmaceuticals, Inc. filed its 2024 10-K on March 26, 2025, reporting on its fiscal year ending December 31, 2024. The company, focused on pharmaceuti
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX